Characteristics and molecular basis of celecoxib modulation on K(v)7 potassium channels | |
Du, X. N.2; Zhang, X.2; Qi, J. L.2,3; An, H. L.1; Li, J. W.1; Wan, Y. M.2; Fu, Y.3; Gao, H. X.2; Gao, Z. B.4; Zhan, Y.1 | |
刊名 | BRITISH JOURNAL OF PHARMACOLOGY |
2011-11 | |
卷号 | 164期号:6页码:1722-1737 |
关键词 | activation of potassium channels celecoxib HEK 293 cell K(v)7 NSAIDs retigabine SCG |
ISSN号 | 0007-1188 |
DOI | 10.1111/j.1476-5381.2011.01483.x |
文献子类 | Article |
英文摘要 | BACKGROUND AND PURPOSE Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor used for the treatment of pain and inflammation. Emerging and accumulating evidence suggests that celecoxib can affect cellular targets other than COX, such as ion channels. In this study, we characterized the effects of celecoxib on K(v)7 K+ channels and compared its effects with the well-established K(v)7 channel opener retigabine. EXPERIMENTAL APPROACH A perforated whole-cell patch technique was used to record K(v)7currents expressed in HEK 293 cells and M-type currents from rat superior cervical ganglion neurons. KEY RESULTS Celecoxib enhanced K(v)7.2-7.4, K(v)7.2/7.3 and K(v)7.3/7.5 currents but inhibited K(v)7.1 and K(v)7.1/KCNE1 currents and these effects were concentration dependent. The IC50 value for inhibition of K(v)7.1 channels was approximately 4 mu M and the EC50 values for activation of K(v)7.2-7.4, K(v)7.2/K(v)7.3 and K(v)7.3/K(v)7.5 channels were approximately 2-5 mu M. The effects of celecoxib were manifested by increasing current amplitudes, shifting the voltage-dependent activation curve in a more negative direction and slowing the deactivation of K(v)7 currents. 2,5-Dimethyl-celecoxib, a celecoxib analogue devoid of COX inhibition activity, has similar but greater effects on K(v)7currents. K(v)7.2(A235T) and K(v)7.2(W236L) mutant channels, which have greatly attenuated responses to retigabine, showed a reversed response to celecoxib, from activation to inhibition. CONCLUSIONS AND IMPLICATIONS These results suggest that K(v)7 channels are targets of celecoxib action and provide new mechanistic evidence for understanding the effects of celecoxib. They also provide a new approach to developing K(v)7 modulators and for studying the structure-function relationship of K(v)7 channels. |
资助项目 | National Natural Science Foundation of China[30730031] ; National Natural Science Foundation of China[30500112] ; 973 Program[2007CB512100] ; National Science Fund for Distinguished Young Scholars of China[30325038] |
WOS关键词 | SENSORY NEURONS ; K+ CHANNELS ; ACTIVATION ; ANTICONVULSANT ; INHIBITION ; RETIGABINE ; CURRENTS ; METAANALYSIS ; PHYSIOLOGY ; K(V)LQT1 |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | WILEY-BLACKWELL |
WOS记录号 | WOS:000296908300015 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/278359] |
专题 | 神经药理学研究国际科学家工作站 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
通讯作者 | Zhang, H. L. |
作者单位 | 1.Hebei Univ Technol, Inst Biophys, Tianjin, Peoples R China; 2.Hebei Med Univ, Dept Pharmacol, Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang 050017, Hebei, Peoples R China; 3.Hebei Med Univ, Dept New Drug Dev, Shijiazhuang 050017, Hebei, Peoples R China; 4.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Discovery & Design, State Key Lab Drug Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China |
推荐引用方式 GB/T 7714 | Du, X. N.,Zhang, X.,Qi, J. L.,et al. Characteristics and molecular basis of celecoxib modulation on K(v)7 potassium channels[J]. BRITISH JOURNAL OF PHARMACOLOGY,2011,164(6):1722-1737. |
APA | Du, X. N..,Zhang, X..,Qi, J. L..,An, H. L..,Li, J. W..,...&Zhang, H. L..(2011).Characteristics and molecular basis of celecoxib modulation on K(v)7 potassium channels.BRITISH JOURNAL OF PHARMACOLOGY,164(6),1722-1737. |
MLA | Du, X. N.,et al."Characteristics and molecular basis of celecoxib modulation on K(v)7 potassium channels".BRITISH JOURNAL OF PHARMACOLOGY 164.6(2011):1722-1737. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论